The global blood group typing market is expected to witness significant growth in the coming years, driven by the increasing demand for blood transfusions, organ transplantation, and advancements in technology. The market can be segmented based on product type, test type, technique, end-user, and geography. In this article, we will focus on the regional analysis of the blood group typing market and its growth prospects.
North America held the largest share of the global blood group typing market in 2020, owing to the presence of major market players, increasing demand for blood transfusions, and the high incidence of blood disorders in the region. According to the American Red Cross, approximately 36,000 units of red blood cells are needed every day in the United States, and nearly 21 million blood components are transfused each year. Additionally, the increasing adoption of automated blood typing systems is driving the growth of the market in North America.
Europe is the second-largest market for blood group typing, owing to the increasing demand for blood transfusions and the rising incidence of blood disorders in the region. According to the European Commission, approximately 25 million blood donations are collected every year in the European Union, and the demand for blood transfusions is expected to increase in the coming years due to the aging population. Moreover, the presence of major market players in the region is also driving the growth of the market.
Asia Pacific is expected to witness significant growth during the forecast period, owing to the increasing demand for blood typing and the rising incidence of blood disorders in the region. According to the World Health Organization (WHO), approximately 50% of the global burden of anemia is in Asia, and the incidence of blood disorders such as thalassemia and sickle cell anemia is also high in the region. Moreover, the increasing adoption of automated blood typing systems and the presence of a large patient pool are also driving the growth of the market in Asia Pacific.
Latin America and the Middle East and Africa (MEA) are also expected to witness significant growth in the coming years, owing to the increasing demand for blood transfusions and the rising incidence of blood disorders in these regions. In Latin America, the increasing adoption of automated blood typing systems and the presence of major market players are driving the growth of the market. In the MEA region, the increasing incidence of blood disorders such as sickle cell anemia and the growing awareness about blood transfusions are driving the growth of the market.
The key players operating in the global blood group typing market include Grifols, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Quotient Limited, Immucor, Inc., Novacyt Group, Beckman Coulter, Inc., Agena Bioscience, Merck KGaA, and Bioarray Solutions Ltd. These companies are focusing on developing innovative products and expanding their market presence through partnerships, collaborations, and acquisitions. For instance, in February 2021, Beckman Coulter, Inc. announced the launch of the DxOne Inventory Manager, a cloud-based inventory management system for clinical laboratories.
In conclusion, the global blood group typing market is witnessing significant growth, driven by the increasing demand for blood transfusions, organ transplantation, and advancements in technology. North America held the largest share of the market in 2020, while Asia Pacific is expected to witness significant growth during the forecast period. The key players operating in the market are focusing on developing innovative products and expanding their market presence through partnerships, collaborations, and acquisitions. With the increasing demand for blood typing and the rising incidence of blood disorders, the blood group typing market is expected to witness significant growth in the coming years.
